FAMPYRA
Live / Applied — Fifth extension granted (statement of use) (as of 29 Jan 2026)
What this means for you
Not registered yet, but its 01 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97290207
- Mark type
- Stylized text
- Filed
- 01 Mar 2022
- Published for opposition
- 31 Jan 2023
- Attorney of record
- Joseph C. Guagliardo
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system
Owner
- MERZ PHARMACEUTICALS, LLC, RALEIGH, NC, US
- ACORDA THERAPEUTICS, INC., Pearl River, NY, US
- ACORDA THERAPEUTICS, INC., Ardsley, NY, US
Prosecution history
- 29 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jan 2026 — SOU EXTENSION 5 GRANTED
- 11 Sept 2025 — SOU EXTENSION 5 FILED
- 29 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2025 — SOU EXTENSION 4 GRANTED
- 17 Mar 2025 — SOU EXTENSION 4 FILED
- 17 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Jan 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Sept 2024 — SOU EXTENSION 3 GRANTED
- 23 Sept 2024 — SOU EXTENSION 3 FILED
- 23 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 14 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED